Effect of Progestin-primed Ovarian Stimulation Protocol on Outcomes of Aged Infertile Women Who Failed to Get Pregnant in the First IVF/ ICSI Cycle: A Self-controlled Study

Abstract

This study aimed to explore the outcomes of progestin-primed ovarian stimulation protocol (PPOS) in aged infertile women who failed to get pregnant in the first IVF/ICSI-ET cycles with GnRH-a long protocol. A self-controlled study was conducted to retrospectively investigate the clinical outcomes of 104 aged infertile patients who didn't get pregnant in the first IVF/ICSI-ET treatment by stimulating with GnRH-a long protocol (non-PPOS group), and underwent PPOS protocol (PPOS group) in the second cycle between January 2016 and December 2016 in the Center for Reproductive Medicine, Renmin Hospital of Wuhan University. The primary outcomes included clinical pregnancy rate of frozen-thawed embryos transfer (FET) in PPOS group, and good-quality embryo rate in both groups. The secondary outcomes were fertilization rate, egg utilization rate and cycle cancellation rate. The results showed that there were no significant differences in basal follicle stimulating hormone (bFSH), antral follicle count (AFC), duration and total dosage of gonadotropin (Gn), number of oocytes retrieved, intracytoplasmic sperm injection (ICSI) rate, fertilization rate, and cycle cancellation rate between the two groups (P>0.05). However, the oocyte utilization rate and good-quality embryo rate in PPOS group were significantly higher than those in non-PPOS group (P<0.05). By the end of April 2017,62 FET cycles were conducted in PPOS group. The clinical pregnancy rate and embryo implantation rate were 22.58% and 12.70%, respectively. In conclusion, PPOS protocol may provide better clinical outcomes by improving the oocyte utilization rate and good-quality embryo rate for aged infertile patients who failed to get pregnant in the first IVF/ICSI-ET cycles.

Keywords

advanced age / progestin-primed ovarian stimulation / in vitro fertilization and embryo transfer

References

[1] SerourG, MansourR, SerourA, et al.. Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above. Fertil Steril, 2010, 94(5): 1707-1712

[2] YoldemirT. Fertility in midlife women. Climacteric, 2016, 19(3): 240-246

[3] OuJ, XingW, LiY, et al.. Short versus long gonadotropin-releasing hormone analogue suppression protocols in IVF/ICSI cycles in patients of various age ranges. PLoS One, 2015, 10(7): el33887

[4] MarinakisG, NikolaouD. National survey of the current management of infertility in women aged 40 and over in the UK. J Obstet Gynaecol, 2012, 32(4): 375-378

[5] DayaS. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev, 2000, 2: D1299

[6] HuirneJA, LambalkC v, LoenenAC, et al.. Contemporary pharmacological manipulation in assisted reproduction. Drugs, 2004, 64(3): 297-322

[7] BaerwaldAR, AdamsGP, PiersonRA. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril, 2003, 80(1): 116-122

[8] KuangY, HongQ, ChenQ, et al.. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertil Steril, 2014, 101(1): 105-111

[9] KuangY, ChenQ, HongQ, et al.. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reprod Biomed Online, 2014, 29(6): 684-691

[10] QinN, ChenQ, HongQ, et al.. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril, 2016, 106(2): 334-341

[11] KuangY, ChenQ, FuY, et al.. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril, 2015, 104(1): 62-70

[12] CumminsJM, BreenTM, HarrisonKL, et al.. A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J In Vitro Fert Embryo Transf, 1986, 3(5): 284-295

[13] OttenAB, SmeetsH J. Evolutionary defined role of the mitochondrial DNA in fertility, disease and ageing. Hum Reprod Update, 2015, 21(5): 671-689

[14] MoragianniVA, PenziasAS. Cumulative live-birth rates after assisted reproductive technology. Curr Opin Obstet Gynecol, 2010, 22(3): 189-192

[15] XuHJ, JiXW, HongY, et al.. Mini-dose GnRH-a long versus short protocol in patients >35 years old undergoing in vitro fertilization. Gynecol Endocrinol, 2014, 30(7): 498-501

[16] HendriksDJ, KweeJ, MolBW, et al.. Ultrasonography as a tool for the prediction of outcome in I VF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril, 2007, 87(4): 764-775

[17] SamanthaP, SamanthaB, DanielD, et al.. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril, 2015, 103(3): e9-el7

[18] WangY, ChenQ, WangN, et al.. Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: A double-blind randomized crossover clinical trial. Medicine, 2016, 95(9): e2939

[19] BormanSM, ChaffinCL, SchwinofKM, et al.. Progesterone promotes oocyte maturation, but not ovulation, in nonhuman primate follicles without a gonadotropin surge. Biol Reprod, 2004, 71(l): 366-373

[20] MorganPM, BoatmanDE, BavisterBD. Relationships between follicular fluid steroid hormone concentrations, oocyte maturity, in vitro fertilization and embryonic development in the rhesus monkey. Mol Reprod Dev, 1990, 27(2): 145-151

[21] WangN, WangY, ChenQ, et al.. Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study. Clin Endocrinol, 2016, 84(5): 720-728

[22] UbaldiFM, CapalboA, VaiarelliA, et al.. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertil Steril, 2016, 105(6): 1488-1495

[23] ZhangS, ChenY, WangX, et al.. Analysis of progestin-primed ovarian stimulation and atypical mild stimulation during IVF treatment in poor ovarian response women. Reprod Contracept, 2016, 12(36): 981-985

[24] MassinN. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Hum Reprod Update, 2017, 23(2): 211-220

[25] GrossKM, MatsumotoAM, BremnerWJ. Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man. J Clin Endocrinol Metab, 1987, 64(4): 675-680

[26] WildtL, HutchisonJS, MarshallG, et al.. On the site of action of progesterone in the blockade of the estradiolinduced gonadotropin discharge in the rhesus monkey. Endocrinology, 1981, 109(4): 1293-1294

[27] RichterTA, RobinsonJE, LozanoJM, et al.. Progesterone can block the preovulatory gonadotropin-releasing hormone/luteinising hormone surge in the ewe by a direct inhibitory action on oestradiol-responsive cells within the hypothalamus. J Neuroendocrinol, 2005, 17(3): 161-169

[28] CoboA, KuwayamaM, PerezS, et al.. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril, 2008, 89(6): 1657-1664

[29] RienziL, RomanoS, AlbricciL, et al.. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized siblingoocyte study. Hum Reprod, 2010, 25(l): 66-73

[30] RoqueM, ValleM, GuimaraesF, et al.. Freeze-all policy: fresh vs. frozen-thawed embryo transfer. Fertil Steril, 2015, 103(5): 1190-1193

[31] ChenH, WangY, LyuQ, et al.. Comparison of livebirth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles. Fertil Steril, 2015, 103(5): 1194-1201

[32] HuangB, HuD, QianK, et al.. Is frozen embryo transfer cycle associated with a significantly lower incidence of ectopic pregnancy? An analysis of more than 30,000 cycles. Fertil Steril, 2014, 102(5): 1345-1349